Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids - Wikidata - awgldk - TriplyDB

Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids

Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids

http://www.wikidata.org/entity/Q33966666

about

Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity Feline Immunodeficiency Virus Cross-Species Transmission: Implications for Emergence of New Lentiviral Infections.A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 Evolution of puma lentivirus in bobcats (Lynx rufus) and mountain lions (Puma concolor) in North America.Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.The role of BST2/tetherin in feline retrovirus infection Vif determines the requirement for CBF-β in APOBEC3 degradation Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep.Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission.Retroviral restriction and dependency factors in primates and carnivores.Primate and feline lentiviruses in current intrinsic immunity research: the cat is back.Cellular restriction factors of feline immunodeficiency virus.The molecular biology of feline immunodeficiency virus (FIV).Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.Productive replication and evolution of HIV-1 in ferret cells.Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction.Construction and testing of orfA +/- FIV reporter viruses Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases.A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.Identification of a conserved interface of HIV-1 and FIV Vifs with Cullin 5.New World feline APOBEC3 potently controls inter-genus lentiviral transmission.Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses

P2860

Q21144862-708CFD22-0FBD-439F-B11A-67D61944D74C Q31150529-F2F8598C-04A3-4264-A34B-E706CD4A2812 Q33651576-9015E164-7021-4EF3-B828-113D6BD16620 Q33690901-78168C87-9310-46FE-942B-86795A24E4B0 Q33900310-CE20F9DD-AB4F-4B58-A441-D7C421A6F1D2 Q34261416-9FC6C20D-DD1D-4B95-838F-E2BD8CBD5ADB Q34539110-B3416B5D-2B50-4A1F-AEE6-AC23D41F0038 Q34664616-8C493DF9-3B51-4807-96C5-1DE462707A7B Q35182748-CEA70617-ECC9-451C-B660-786CD1693FF4 Q35531709-FA863417-8A28-4DAA-A725-EA0E90FFDB32 Q36432758-D56A8B78-3950-4A2E-AA59-42CB6D65174B Q36667953-EC39858B-C4AD-4FE7-99BE-AD2924480A9D Q36978615-52629C23-3306-4048-9389-E7F414392637 Q37059673-BC0CD8D5-1AE2-4FC4-BB40-9789D376DBD2 Q37357336-4E601AB4-2692-4FF3-8593-97248A46DB5D Q37619606-55257885-27EF-4603-AADF-C03124DC0161 Q37895742-FE5387F7-E5AB-45FC-AB1E-A3DCB54B1E55 Q37895745-DCC9AC8E-C6AE-4321-90EF-3E57AA68E01B Q37954259-452E5C8F-4724-4652-A64B-61AE4BE6CCF0 Q37967732-C1E3F165-6E5C-4706-9539-13D17E05E829 Q38326209-CE19502B-5C4A-4E97-B442-B4007C7D8067 Q38746224-27760F9C-AF10-4A19-903D-7C9AC5C74397 Q38997444-68912C36-6BA7-4FE2-80DB-257FDB85EDC7 Q39121252-8AEBAA3F-C528-4919-A5D0-A83F3D1EBA66 Q39392326-AB7FBBA5-6CC8-4EBC-A361-5A1FBED44CD3 Q39595254-FE8A1C62-3CEF-48EE-88C9-CD06E0CCD016 Q40941381-968A7537-5AAF-4F27-BA0E-ED3590748FA8 Q47269109-A4CF3F58-0713-49D4-AA94-2662AF4E60F7 Q52595645-0DF4CBEC-6B58-4BC3-854A-D72543FF4009 Q54209747-256A7B44-A0B8-470F-BFE6-A686E1A5DEA3 Q54237606-C7B45D79-654A-4252-998A-DD4D07DDD13A Q56977004-563BDE1E-D388-4E01-AE86-5132BC294F23

P2860

Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids

http://www.wikidata.org/entity/Q33966666

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vif of feline immunodeficiency ...... ction factors from many felids

@ast

Vif of feline immunodeficiency ...... ction factors from many felids

@en

type

label

Vif of feline immunodeficiency ...... ction factors from many felids

@ast

Vif of feline immunodeficiency ...... ction factors from many felids

@en

prefLabel

Vif of feline immunodeficiency ...... ction factors from many felids

@ast

Vif of feline immunodeficiency ...... ction factors from many felids

@en

P1433

Q33966666-A678C458-EA4C-43DF-A109-AB5168D01DF4

P1476

Q33966666-8B27345E-DB1D-4838-903D-70C19515859E

P2093

Q33966666-7AB38E88-136F-4D50-BCE3-6410BBAB3515

Q33966666-87AE43E3-95D6-4C17-92FA-86E3BC5E0A4A

Q33966666-A11B6768-8817-4C19-B839-AC08DE3D0C80

Q33966666-C3AA1809-FFD2-43A6-84B6-F45F501546A3

Q33966666-DD69C7C5-0DBD-4FE6-B430-B690433F88D4

Q33966666-F5390FCE-1901-49A7-9BF1-1967C7E5D3E2

P2860

Q33966666-0E862BCD-45D9-405B-8A22-E341B5BB7FC6

Q33966666-0F54EE14-050D-4B00-824F-BDCC5908C142

Q33966666-11DBE010-A395-4D24-948F-7EC0E224792F

Q33966666-1603D2BC-3D67-499A-917E-A63B0AB8CA74

Q33966666-169AE030-48C2-4884-9B7B-BD4E573E0967

Q33966666-1728E952-312B-454D-856D-36D2C8F0918D

Q33966666-199AA44C-BC26-4852-B088-F624957F89F1

Q33966666-1BC45F1A-94F9-420A-BF25-9139B624518B

Q33966666-1CBBB93A-061D-4D6F-8D0B-36DCD85F8E0D

Q33966666-208FAB3A-5606-49E1-93CA-417D2EAF3283

P304

Q33966666-0F1B1A3E-D2C1-4372-B1DB-784890558859

P31

Q33966666-4CF2B30D-B7DA-4C0C-96BE-245E8A095C51

P356

Q33966666-3B00C39F-1346-42D2-8E61-76F7E3F3F9D6

P407

Q33966666-3F33097A-4CB0-442F-B254-5EDDEEE8B16E

P433

Q33966666-B59F4DED-EBFD-42CE-90DB-BD697BE7C131

P478

Q33966666-A0CD8650-821D-4D61-9C71-48385659011C

P577

Q33966666-13B66B16-D6E5-4F2E-8D57-0D624638AADD

P698

Q33966666-72358AD3-FFF0-4E23-82F6-9E66050391DA

P932

Q33966666-EC7A65D2-2C3F-4CEE-8124-A64B81CDDA98

P356

P1433

Journal of Virology

P1476

Vif of feline immunodeficiency ...... ction factors from many felids

@en

P2093

Carsten Münk

http://www.w3.org/2001/XMLSchema#string

Daniela Marino

http://www.w3.org/2001/XMLSchema#string

Henning Hofmann

http://www.w3.org/2001/XMLSchema#string

Jörg Zielonka

http://www.w3.org/2001/XMLSchema#string

Martin Löchelt

http://www.w3.org/2001/XMLSchema#string

Naoya Yuhki

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroelement activity of APOBEC3H was lost twice in recent human evolution

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation

Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex

Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology

P304

7312-7324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00209-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20444897

http://www.w3.org/2001/XMLSchema#string

P932

2898260

http://www.w3.org/2001/XMLSchema#string